US 10,376,381 B2
Interbody bone implant device
William F. McKay, Memphis, TN (US)
Assigned to Warsaw Orthopedic, Inc., Warsaw, IN (US)
Filed by Warsaw Orthopedic, Inc., Warsaw, IN (US)
Filed on Jul. 6, 2017, as Appl. No. 15/643,091.
Application 15/643,091 is a continuation of application No. 13/448,647, filed on Apr. 17, 2012, granted, now 9,730,801.
Prior Publication US 2017/0296357 A1, Oct. 19, 2017
Int. Cl. A61F 2/28 (2006.01); A61F 2/30 (2006.01); A61F 2/44 (2006.01); A61F 2/46 (2006.01); A61L 27/18 (2006.01); C08L 71/00 (2006.01)
CPC A61F 2/4455 (2013.01) [A61L 27/18 (2013.01); A61F 2/4611 (2013.01); A61F 2002/2835 (2013.01); A61F 2002/30059 (2013.01); A61F 2002/30448 (2013.01); A61F 2002/30784 (2013.01); A61F 2002/30904 (2013.01); A61L 2430/02 (2013.01)] 7 Claims
OG exemplary drawing
 
1. A composite interbody bone implant device comprising: a body, which comprises a non-bone composition formed into a shape and including a plurality of cavities, the non-bone composition comprising a polymer comprising poly-ether-ketone-ketone (PEKK), poly-ether-ether-ketone (PEEK), or a combination thereof; and an osteoinductive material provided within said cavities of the body, wherein the body is formable into a shape and size configured for implantation at an intervertebral endplate; the osteoinductive material comprising demineralized bone matrix fibers and demineralized bone matrix chips in a 30:60 ratio, and the demineralized bone matrix chips are surface demineralized and the demineralized bone fibers are fully demineralized, wherein the device has a surface area, wherein 5% to 50% of the surface area is configured to contact host bone at the intervertebral endplate and the osteoinductive material further comprises allograft bone material from about 10% to about 60% by weight of the device.